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Summary 
To identify genes involved in cardiac arrhythmia, we 
investigated patients with long QT syndrome (LQT), 
an inherited disorder causing sudden death from a 
ventricular tachyarrhythmia, torsade de pointes. We 
previously mapped LQT loci on chromosomes 11 
(LQT1), 7 (LQT2), and 3 (LQT3). Here, linkage and phys- 
ical mapping place LQT2 and a putative potassium 
channel gene, HERG, on chromosome 7q35-36. Single 
strand conformation polymorphism and DNA sequence 
analyses reveal HERG mutations in six LQT families, 
including two intragenic deletions, one splice-donor 
mutation, and three missense mutations. In one kin- 
dred, the mutation arose de novo. Northern blot analy- 
ses show that HERG is strongly expressed in the heart. 
These data indicate that HERG is LQT2 and suggest 
a likely cellular mechanism for torsade de pointes. 
Introduction 
Long QT syndrome (LQT) is an inherited cardiac disorder 
that causes syncope, seizures, and sudden death, usually 
in young, otherwise healthy individuals (Ward, 1964; Ro- 
mano, 1965; Schwartz et al., 1975). Most LQT gene carriers 
manifest prolongation of the QT interval on electrocardio- 
grams, a sign of abnormal cardiac repolarization (Vincent 
et al., 1992). The clinical features of LQT result from epi- 
sodic cardiac arrhythmias, specifically torsade de pointes, 
named for the characteristic undulating natu re of the elec- 
trocardiogram in this arrhythmia. Torsade de pointes may 
degenerate into ventricular fibrillation, a particularly lethal 
arrhythmia. Although LQT is not a common diagnosis, ven- 
tricular arrhythmias are very common; more than 300,000 
Americans die suddenly every year (Kannel et al., 1987; 
Willich et al., 1987), and in many cases the underlying 
mechanism may be aberrant cardiac repolarization. LQT, 
therefore, provides a unique opportunity to study life- 
threatening cardiac arrhythmias at the molecular level. 
A molecular basis for LQT was not previously known. 
In 1991, we discovered tight linkage between autosomal 
dominant LQT and a poiymorphism at H-RAS (Keating et 
al., 1991a). This discovery localized an LQT gene (LQT1) 
to chromosome 1 lp15.5 and made genetic testing possi- 
ble in some families. Autosomal dominant LQT was pre- 
viously thought o be genetically homogeneous, and the 
first seven families that we studied were linked to 1 lp15.5 
(Keating et al., 1991b). In 1993, however, several labora- 
tories, including our group, identified families that were 
not linked to chromosome 11 p15.5 (Benhorin et al., 1993; 
Curran et al., 1993a; Towbin et al., 1994). In 1994, we 
identified two additional LQT loci, LQT2 on chromosome 
7q35-36 (nine families) and LQT3 on chromosome 3p21-24 
(three families) (Jiang et al., 1994). Since three families 
in our study remained unlinked, at least one more LQT 
locus exists. This degree of heterogeneity suggests that 
distinct LQT genes may encode proteins that interact to 
modulate cardiac repolarization and arrhythmia risk. 
Since LQT is associated with abnormal cardiac repolar- 
ization, genes that encode ion channels (or their modu- 
lators) are reasonable candidates. H-RAS, which was lo- 
calized to chromosome 1 lp15.5, was excluded as a 
candidate for LQT1 based on direct DNA sequence analy- 
ses (unpublished ata) and by linkage analyses (Roy et 
al., 1994). A skeletal muscle chloride channel (CLCN1; 
Koch et al., 1992) and a cardiac muscarinic-acetylcholine 
receptor (CHRM2; Bonner et al., 1987) became candidates 
for LQT2 based on their chromosome 7q35-36 location, but 
subsequent linkage analyses have excluded these genes 
(Wang et al., submitted). 
Warmke and Ganetzky (1994) identified a novel human 
cDNA, the human ether-a-go-go-related gene (HERG). 
HERG was localized to human chromosome 7 by polymer- 
ase chain reaction (PCR) analysis of a somatic cell hybrid 
panel (Warmke and Ganetzky, 1994). The function of the 
protein encoded by HERG is not known, but it has pre- 
dicted amino acid sequence homology to potassium chan- 
nels. HERG was isolated from a hippocampal cDNA library 
by homology to the Drosophila ether-a-go-go (eag) gene, 
which encodes a Ca2+-modulated potassium channel 
(Bruggeman et al., 1993). HERG is not the human homolog 
of eag, however, their products sharing only -50% amino 
acid sequence homology. 
In this study, we provide evidence indicating that HERG 
is LQT2. First, we identified and characterized new LQT 
families and showed that all were linked to markers on 
chromosome 7q35-36, confirming the location of LQT2. 
Second, we mapped HERG to chromosome 7q35-36, mak- 
ing HERG a candidate gene for LQT2. Third, we demon- 
strated that HERG is strongly expressed in the heart. Fi- 
nally, we identified six HERG mutations associated with 
LQT; one of these mutations arose de novo. 
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Figure 1. Pedigree Structure and Genotypic Analyses of Five LQT Families 
Individuals showing the characteristic features of LQT, including prolongation of the QT interval and history of syncope, seizures, or aborted 
sudden death, are indicated by closed circles (females) or closed squares (males). Unaffected individuals are indicated by open circles or open 
squares. Individuals with an equivocal phenotype or those for whom phenotypic data are unavailable are shown as stippled. Circles or squares 
with a slash denote deceased individuals. Haplotypes for polymorphic markers linked to LQT2 are shown under each individual. These markers 
include (centromere to telomere) D78505, D78636, HERG 5-11, HERG 3-8, and D7S483 (Gyapay et al., 1994; Wang et al., submitted). Haplotypes 
cosegregating with the disease phenotype are indicated by a box. Recombination events are indicated with a horizontal black line. Informed 
consent was obtained from all individuals or from their guardians in accordance with local institutional review board guidelines. Haplotype analyses 
indicate that the LQT phenotype in these kindreds is linked to markers on chromosome 7q35-36. 
Results 
LQT2 Is L inked to Markers on 
Chromosome 7q35-36 
To determine the relative frequency of the three known 
LQT loci (LQT1, LQT2, and LQT3), we performed linkage 
analyses in families with this disorder. Five LQT families 
were identified and phenotypically characterized (Figure 
1). These families were unrelated and of varying descent, 
including Mexican (Spanish), German, English, and Dan- 
ish. In each case, an autosomal dominant pattern of inheri- 
tance was suggested by inspection of the pedigree. Af- 
fected individuals were identified by the presence of QT 
prolongation on electrocardiograms and, in some cases, 
a history of syncope or aborted sudden death. No patients 
had signs of congenital neural hearing loss, a finding asso- 
ciated with the rare autosomal recessive form of LQT, or 
other phenotypic abnormalities. Genotype analyses with 
polymorphic markers linked to the known LQT loci sug- 
gested that the disease phenotype in these families was 
linked to polymorphic markers on chromosome 7q35-36 
(Figure 1). The maximum combined two-point Iod score 
for these five families was 5.13 at D78636 (~) = 0.0; Table 
1). When combined with our previous studies (Jiang et al., 
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Table 1. Maximum Pairwise Lod Scores, Recombination Fractions 
for Linkage of LQT2 with HERG, and Polymorphic Markers on 
Chromosome 7
Families from Families Studied 
Present Study to Date 
LOCUS Z=,~ 0 Zm~ 0 
D7S505 4.40 0.0 22.91 0.009 
D7S636 5.13 0.0 26.14 0.00 
HERG 3-8 0.11 0.0 6.34 0.00 
HERG 5-11 3.55 0.0 9.64 0.00 
D7S483 2.48 O.0 22.42 0.00 
Markers are shown in chromosomal order (centromere to telomere) 
(Gyapay et al., 1994). The first column (families from present study) 
indicates combined Iod scores for the five families described in this 
study. The second column (families tudied to date) indicates com- 
bined Iod scores from the five families studied here, as well as the 
nine families from our previous tudy (Jiang et al., 1994). Zm~ indicates 
maximum Iod score; e indicates estimated recombination fraction at 
Zmax, 
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Figure 2. Partial Genomic Structure of HERG and Location of PCR 
Primers Used in This Study 
Regions encoding predicted membrane-spanning domains ($1-$6), 
the pore domain, and the nucleotide-binding domain (NBD) are indi- 
cated. The DNA sequences for the intron-exon boundaries are these: 
intron I, 5'-AGGAGgtgggg._ccccagCTGATC-3'; intron II, 5"TGG- 
CTgtgagt...ccccagCCCTC-3'; intron Ill, 5'-CCTGGgtatgg...ctccagG- 
GAAG-3'. 
1994; Wang et al., submitted), the maximum combined 
two-point Iod score for the 14 chromosome 7-1inked fami- 
lies was 26.14, also at D7S636 (0 = 0.0; Table 1). Haplo- 
type analyses were consistent with our previous studies, 
placing LQT2 between D7S505 and D7S483 (Figure 1; 
Wang et al., submitted), localizing this gene to chromo- 
some 7q35-36. 
HERG Maps to Chromosome 7q35-36 
HERG was previously mapped to chromosome 7 (Warmke 
and Ganetzky, 1994). To test the candidacy of this gene, 
we refined the localization of HERG using two physical 
mapping techniques. First, we mapped HERG on a set of 
yeast artificial chromosome (YAC) contigs constructed for 
chromosome 7 (Green et al., 1994). HERG was localized 
to the same YAC as D7S505, a polymorphic marker that 
was tightly linked to LQT2 (Table 1). Second, we mapped 
HERG to chromosome 7q35-36 using fluorescent in situ 
hybridization (FISH) with a P1 genomic clone containing 
HERG (data not shown). 
To determine whether HERG was genetically linked to 
the LQT locus, we used single strand conformation poly- 
morphism (SSCP) analyses to identify polymorphisms 
within HERG and performed linkage analyses in the chro- 
mosome 7-1inked families. Two aberrant SSCP conform- 
ers were identified in DNA samples from patients and con- 
trols using primer pairs 5-11 and 3-8 (Figure 2). These 
conformers were cloned and sequenced. One abnormal 
conformer resulted from a C to T substitution at position 
3 of codon 489 (cDNA nucleotide 1467; observed hetero- 
zygosity of 0,37). The second abnormal conformer re- 
suited from an A to G substitution at position 3 of codon 
564 (cDNA nucleotide 1692; observed heterozygosity of 
0.44). Neither substitution affected the predicted amino 
acid sequence of HERG. HERG polymorphisms were used 
for genotypic analyses in chromosome 7-1inked families 
(see Figure 1; data not shown). No recombination events 
between HERG and LQT were identified in any of these 
families. The maximum combined Iod score for the 14 
families was 9.64 (0 = 0.0; Table 1). These data indicate 
that HERG is completely linked to LQT2. 
HERG Intragenic Deletions Associated 
with LQT in Two Families 
To test the hypothesis that HERG is LQT2, we used SSCP 
analyses to screen for mutations in affected individuals. 
Since the genomic structure of HERG was unknown, oligo- 
nucleotide primer pairs were designed from published 
(Warmke and Ganetzky, 1994) HERG cDNA sequences 
(Figure 2; Table 2). In most cases, single products of ex- 
pected size were generated. For primer pairs 1-10, 6-13, 
and 15-17, however, products of greater than expected 
size were obtained, suggesting the presence of intronic 
sequences. To examine this possibility, we cloned and 
sequenced these larger products. DNA sequence analy- 
ses identified three introns at positions 1557/1558, 1945/ 
Table 2. HERG PCR Primers 
Name Posit ion Sequence 
1L 1147-1166 
2 L 1291-1312 
3 L 1417-1437 
4 L Intronl 
5 L 1618-1636 
6 L 1802-1823 
7 R 1446-1426 
8 R 1527-1503 
9 R Intronl 
10 R 1643-1623 
11R 1758-1736 
12 R Intron II
13 R 2034-2016 
16 R Intron III 
15 L 2259-2278 
14 L 2214-2233 
17 R 2550-2529 
GACGTGCTGCCTGAGTACAA 
TTCCTGCTGAAGGAGACGGAAG 
ACCACCTACGTCAATGCCAAC 
TGCCCCATCAACGGAATGTGC 
GATCGCTACTCAGAGTACG 
GCCTGGGCGGCCCCTCCATCAA 
CACCTCCTCGTTGGCATTGAC 
GTCGAAGGGGATGGCGGCCACCATG 
TACACCACCTGCCTCCTTGCTGA 
GCCGCGCCGTACTCTGAGTAG 
CAGCCAGCCGATGCGTGAGTCCA 
GCCCGCCCCTGGGCACACTCA 
CAGCATCTGTGTGTGGTAG 
GGCATTTCCAGTCCAGTGC 
CCTGGCCATGAAGTTCAAGA 
GCACTGCAAACCCTTCCGAG 
GTCGGAGAACTCAGGGTACATG 
All primers are shown in 5' to 3' direction. Sense strand oligonucleo- 
tides are indicated with an L and antisense oligonucleotides are indi- 
cated with an R. cDNA sequence was obtained from the GenBank 
data base; nucleotide numbering begins with the initiator methionine. 
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Figure 3. HERG Intragenic Deletions Associated with LQT in Two Families 
(A) Pedigree structure ofK2287, results of PCR amplification using primer pair 3-9, and the effect of the deletion on the predicted structure of 
HERG protein are shown. Note that an aberrant fragment of 143 bp is observed in affected members of this kindred, indicating the presence of 
a disease-associated intragenic deletion. DNA sequence of normal and aberrant PCR products defines a 27 bp deletion (AI500-F508). This mutation 
causes an in-frame deletion of nine amino acids in the third membrane-spanning domain ($3). Deleted sequences are indicated. 
(B) Pedigree structure of K2595 is shown. Deceased individuals are indicated by a slash. The results of SSCP analyses using primer pair 1-9 are 
shown beneath each individual. Note that an aberrant SSCP conformer cosegregates with the disease in this family. DNA sequence shows a 
single base pair deletion (A1261). This deletion results in a frameshift ollowed by a stop codon 12 amino acids downstream. The deleted nucleotide 
is indicated with an arrow. 
1946, and 2398•2399 of the cDNA sequence (Figure 2). 
These boundaries were confirmed by direct DNA sequenc- 
ing of HERG genomic clones containing HERG (data not 
shown). To facilitate SSCP analyses, we designed addi- 
tional primers to intronic sequences. 
As indicated previously, SSCP analyses using primer 
pair 3-8 identified an A to G polymorphism within HERG 
(cDNA nucleotide 1692). Analysis of kindred 2287 (1<2287) 
using this SSCP defined a pattern of genotypes consistent 
with a null allele (see Figure 1). Possible explanations for 
these findings included multiple misinheritances, a possi- 
bility not supported by our previous genotypic analyses, 
DNA sample errors, base pair substitutions, or a deletion. 
To test the hypothesis that the genotypic data were due 
to a small deletion, we repeated PCR analyses of K2287 
using a new primer pair (3-9) flanking the previous set of 
primers. These experiments identified two products of 170 
bp and 143 bp in affected members of K2287 (Figure 3A). 
By contrast, only a single product of 170 bp was observed 
in unaffected members of this kindred. Furthermore, only 
the 170 bp band was seen in DNA samples from more 
than 200 unaffected individuals (data not shown). The 143 
bp and 170 bp products were cloned from affected individ- 
ual 11-2. Direct sequence analyses of the aberrant PCR 
product revealed the presence of a 27 bp deletion begin- 
ning at position 1498 (AI500-F508). This deletion disrupts 
the third membrane-spanning domain (S3) of HERG. 
To test further the hypothesis that HERG is LQT2, we 
continued SSCP analyses in additional kindreds, SSCP 
using the primer pair 1-9 identified an aberrant conformer 
in affected individuals of K2595 (Figure 3B). Analyses of 
more than 200 unaffected individuals failed to show this 
anomaly (data not shown). The normal and aberrant con- 
formers were cloned and sequenced, revealing a single 
base deletion at position 1261 (A1261). This deletion re- 
sults in a frameshift in sequences encoding the first mem- 
brane-spanning domain ($1), leading to a new stop codon 
within 12 amino acids. The identification of intragenic dele- 
tions of HERG in two LQT families suggests that HERG 
mutations can cause LQT. 
Three HERG Point Mutations Associated with LQT 
To identify additional HERG mutations in LQT2, we contin- 
ued SSCP analyses in linked kindreds and sporadic cases. 
Three aberrant SSCP conformers were identified in af- 
fected members of K1956, K2596, and K2015 (Figure 4). 
In each case, the normal and aberrant conformers were 
cloned and sequenced. In K1956, a C to T substitution 
at position 1682 was identified. This mutation results in 
substitution of valine for a highly conserved alanine at 
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Figure 4. HERG Point Mutations identified in Three LQT Kindreds 
Pedigree structure of K1956 (A), K2596 (B), and K2015 (C) are shown. Below each pedigree, the results of SSCP analyses with primer pair 5-11 
(K1956), primer pair 1-9 (K2596), and primer pair 14-16 (K2015) are shown. Aberrant SSCP conformers cosegregate with the disease in each 
kindred. DNA sequence analyses of the normal and aberrant conformers reveals a C to T substitution at position 1682 in K1956. This mutation 
results in substitution of valine for a highly conserved alanine residue at codon 561 (A561V). Analyses of K2596 reveals an A to G substitution 
at position 1408 (T to C substitution on the antisense strand is shown). This mutation results in substitution of aspartic acid for a conserved 
asparagine in the second transmembrane domain (N470D). Analyses of K2015 reveals a G to C substitution (C to G substitution on the antisense 
strand is shown). This mutation occurs inthe splice-donor sequence of intron III. Coding sequences are shown in uppercase and intronic sequences 
are lowercase. Note that he G to C substitution disrupts the splice-donor site (HERG, M-eag, elk [Warmke and Ganetzky, 1994]; R-eag [Ludwig 
etal., 1994]). 
codon 561 (A561V), altering the fifth membrane-spanning 
domain ($5) of the HERG protein (Figure 4A). In K2596, 
an A to G substitution was identified at position 1408. This 
mutation results in substitution of aspartic acid for a con- 
served asparagine at codon 470 (N470D), located in the 
second membrane-spanning domain ($2) (Figure 4B). In 
K2015, a G to C substitution was identified. This substitu- 
tion disrupts the splice-donor sequence of intron III, affect- 
ing the cyclic n ucleotide-binding domain (Figure 4C). None 
of the aberrant conformers were identified in DNA samples 
from more than 200 unaffected individuals (data not 
shown). 
De Novo Mutation of HERG in a 
Sporadic Case of LQT 
To substantiate that HERG mutations cause LQT, we used 
SSCP analysis to screen for mutations in sporadic cases. 
Primer pair 4-12 identified an aberrant conformer in af- 
fected individual II-1 of K2269 (Figure 5). This conformer 
was not identified in either parent or in more than 200 
unaffected individuals. Direct DNA sequencing of the ab- 
errant conformer identified a G to A substitution at position 
1882. This mutation results in substitution of serine for a 
highly conserved glycine at codon 628 (G628S), altering 
the pore-forming domain. Genotype analysis of this kin- 
dred using nine informative short tandem repeat polymor- 
phisms confirmed maternity and paternity. The identifica- 
tion of a de novo mutation in a sporadic case demonstrates 
that HERG is LQT2. 
HERG Is Expressed in the Heart 
HERG was originally identified from a hippocampal cDNA 
library (Warmke and Ganetzky, 1994). To determine the 
tissue distribution of HERG mRNA, we isolated partial 
cDNA clones and used them in Northern blot analyses. 
Northern blot analyses showed strongest hybridization to 
heart mRNAs, with faint signals in brain, liver, and pan- 
creas (Figure 6). Nonspecific hybridization was also seen 
in lung, possibly due to genomic DNA contamination. The 
size of the bands observed in cardiac mRNA was consis- 
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Figure 5. De Novo Mutation of HERG in a Sporadic Case of LQT 
Pedigree structure of K2269 and SSCP analyses (primer pair 14-16) 
showing an aberrant conformer in a sporadic case of LQT. DNA se- 
quence analyses identified a G to A substitution at position 1882 of 
the cDNA sequence (C to T substitution  the antisense strand is 
shown). Note that this mutation results in the substitution of a serine 
for a highly conserved glycine residue at codon 628 (G628S). This 
amino acid sequence is known to be critical for potassium on selec- 
tivity. 
tent with the predicted size of HERG. Two bands of -4 .1  
and 4.4 kb were identified, possibly due to alternative splic- 
ing or the presence of a second related mRNA. These 
data indicate that HERG is strongly expressed in the heart, 
consistent with its involvement in LQT. 
Discuss ion 
We conclude that mutations in HERG cause the chromo- 
some 7-1inked form of LQT. Several lines of evidence sup- 
port this conclusion. First, we used linkage analyses to 
map an LQT locus (LQT2) to chromosome 7q35-36 in 14 
families. Second, we used physical and genetic mapping 
to place HERG in the same chromosomal region as LQT2. 
Third, we demonstrated that HERG is expressed in the 
heart. Fourth, we identified intragenic deletions of HERG 
associated with LQT in two families. Fifth, we identified 
four HERG point mutations in LQT patients. Finally, one 
of the point mutations arose de novo and occurs within a 
highly conserved region encoding the potassium-selective 
pore domain. 
Our data suggest a likely molecular mechanism for chro- 
mosome 7-1inked LQT. Although the function of HERG is 
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Figure 6. Northern Blot Analysis of HERG mRNA Showing Strong Ex- 
pression in the Heart 
A Northern blot (poly[A] ÷RNA, 2 p~g/lane; Clontech) was probed using 
an HERG cDNA containing nucleotides 679-2239 of the coding se- 
quence. Two cardiac mRNAs of ~ 4.1 and 4.4 kb are indicated. Back- 
ground in mRNA extracted from lung was high, but no specific bands 
were identified. 
not yet known, analyses of its predicted amino acid se- 
quence indicates that it encodes a potassium channel 
subunit Potassium channels are formed from four ~ sub- 
units (MacKinnon, 1991), either as homo- or heterotetra- 
mers (Covarrubias et al., 1991). These biophysical obser- 
vations suggest that combination of normal and mutant 
HERG ~ subunits could form abnormal HERG channels. 
This raises the possibility that HERG mutations have a 
dominant negative affect on potassium channel function. 
The mutations that we identified are consistent with a 
dominant negative mechanism (Figure 7). Two mutations 
result in premature stop codons and truncated proteins 
(A1261 and the splice-donor mutation). In the first case, 
only the amino terminus and a portion of the first mem- 
brane-spanning domain ($1) remain. In the second, the 
carboxyl end of the protein is truncated, leaving all mem- 
brane-spanning domains intact. HERG contains a cyclic 
nucleotide-binding domain near the carboxyl terminus, 
and in both mutations this domain is deleted. In another 
mutation, an in-frame deletion of nine amino acids disrupts 
the third membrane-spanning domain (AI500-F508). Two 
missense mutations also affect membrane-spanning do- 
mains, A561V in the $5 domain and N470D in S2. Both 
mutations affect amino acids conserved in the eag family 
of potassiu m channels and likely alter the secondary struc- 
ture of the protein. The de novo missense mutation G628S 
occurs in the pore-forming domain. This domain is highly 
conserved in all potassium channel a subunits. This muta- 
tion affects a conserved amino acid that is of known impor- 
tance for ion selectivity. When this substitution was intro- 
duced into Shaker H4, potassium ion selectivity was lost 
(Heginbotham et al., 1994). As discussed above, these 
mutations could induce the loss of HERG function. 
Our data have implications for the mechanism of ar- 
rhythmias in LQT. Two hypotheses for LQT have pre- 
viously been proposed (Schwartz et al., 1995). One sug- 
gests that a predominance of left autonomic innervation 
causes abnormal cardiac repolarization and arrhythmias. 
This hypothesis is supported by the finding that rrhyth- 
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Figure 7. Schematic Representation ofthe Predicted Topology of the 
Protein Encoded by HERG and the Location of LQT-Associated Muta- 
tions 
For simplicity, not all amino acids are shown. SSCP analyses identified 
HERG mutations in 4 of the 14 chromosome 7-linked kindreds. 
mias can be induced in dogs by removal of the right stellate 
ganglion. In addition, anecdotal evidence suggests that 
some LQT patients are effectively treated by 13-adrenergic 
blocking agents and by left stellate ganglionectomy 
(Schwartz et al., 1995). The second hypothesis for LQT- 
related arrhythmias uggests that mutations in cardiac- 
specific ion channel genes (or genes that modulate cardiac 
ion channels) cause delayed myocellular epolarization. 
Delayed myocellular epolarization could promote reacti- 
vation of L-type Ca 2÷ channels, resulting in secondary de- 
polarizations (January and Riddle, 1989). These second- 
ary depolarizations are the likely cellular mechanism of 
torsade de pointes arrhythmias (Surawicz, 1989). This hy- 
pothesis is supported by the observation that pharmaco- 
logic block of potassium channels can induce QT prolon- 
gation and repolarization-related arrhythmias in human 
and animal models (Antzelevitch and Sicouri, 1994). The 
discovery that one form of LQT results from mutations in a 
cardiac potassium channel gene supports the myocellular 
hypothesis. 
The presence of a cyclic nucleotide-binding domain in 
HERG suggests a mechanism for the link between altered 
autonomic nervous activity and arrhythmias in LQT. 
13-Adrenergic receptor activation increases intracellular 
cAMP and enhances L-type Ca 2÷ channel function. Cyclic 
AMP may also activate HERG, thereby increasing net out- 
ward current and accelerating the rate of myocellular repo- 
larization. Dominant negative mutations of HERG might 
interrupt the normal modulation of HERG function by 
cAMP, thereby permitting a predominant effect on L-type 
Ca 2+ channel function. The resulting imbalance would in- 
crease the likelihood that enhanced sympathetic tone 
could induce Ca 2÷ channel-dependent secondary depolar- 
izations, the probable cellular mechanism of torsades de 
pointes. 13-Adrenergic blocking agents could act by inter- 
rupting the effect of cAMP on L-type Ca 2÷ channels, possi- 
bly explaining the beneficial effects of 13 blockers in some 
LQT patients. 
The relative frequency of the three LQT loci is not yet 
known. In this study, we identified five new families with 
autosomal dominant LQT, and all were linked to chromo- 
some 7. This brings the total number of chromosome 
7-1inked families to 14. To date, we have linked seven 
families to chromosome 11 (LQT1), 14 families to chromo- 
some 7 (LQT2), and three families to chromosome 3 
(LQT3), and three families remain unlinked (Keating et al., 
1991a, 1991b; Jiang et al., 1994). Although preliminary, 
these data suggest that LQT2 is a common form of inher- 
ited LQT. 
This work may have important clinical implications. Re- 
cently, presymptomatic diagnosis has been possible in 
large families using linkage analysis. Most cases of LQT 
are sporadic, and therefore genetic testing using linkage 
analysis is not feasible. Continued mutational analyses of 
LQT2 will facilitate genetic testing for this form of LQT. 
Identification and characterization of genes responsible 
for other forms of LQT will be necessary for the develop- 
ment of generalized iagnostic tests. Improved diagnostic 
capacity may enable rational therapy. For example, chro- 
mosome 7-1inked LQT patients may respond to potassium 
channel activators, like pinacidil. 
In summary, our results provide the molecular mecha- 
nism of a life-threatening cardiac arrhythmia. Future ex- 
periments will define the specific function of HERG and its 
role in LQT. In addition, we will continue to search for LQT 
genes; these genes will provide further insight into cardiac 
repolarization and repolarization-related arrhythmias. 
Experimental Procedures 
Identification and Phenotyping of LQT Kindreds 
LQT kindreds were ascertained from medical clinics throughout North 
America. Phenotypic riteria were identical to those used in our previ- 
ous studies (Keating et al., 1991a, 1991b; Keating, 1992; Curran et 
al., 1993a; Jiang et al., 1994). Individuals were evaluated for LQT 
based on the QT interval corrected for heart rate (QTc; Bazette, 1920) 
and for the presence of syncope, presence of seizures, and aborted 
sudden death. Informed consent was obtained from all individuals or 
from their guardians in accordance with local institutional review board 
guidelines. Phenotypic data were interpreted without knowledge of 
genotype, 
Genotypic and Linkage Analyses 
Amplification and detection of microsatellite markers were performed 
as described previously (Curran et al., 1993a; Jiang et al., 1994). Poiy- 
morphic markers used in this study were D7S483, D7S636, and 
D7S505 (Gyapay et al., 1994). Pairwise linkage analysis was per- 
formed using the MLINK program of the LINKAGE software package 
(Lathrop et al., 1985). In accordance with our previous tudies, we 
assumed a penetrance of 0.90 and a disease gene frequency of 0.001. 
Gene frequency between males and females was assumed to be 
equal. 
Isolation of HERG Genomic and cDNA Clones 
HERG probes were generated using the products of PCRs with human 
genomic DNA and primer pairs 1-10, 6-13, and 15-I 7. These products 
were cloned, radiolabeled tohigh specific activity, and used to screen 
a human genomic P1 library (Sternberg, 1990). Positive clones were 
purified, characterized, and used for FISH and DNA sequence analy- 
ses. To isolate HERG cDNA clones, genomic probes containing HERG 
coding sequences were used to probe 106 recombinants ofa human 
hippocampal cDNA library (Stratagene). A single clone containing 
-2.2 kb of HERG coding sequence was isolated and characterized. 
YAC-Based Mapping of HERG 
A PCR assay specific for the 3'untranslated region of HERG (employing 
primers 5'-GCTGGGCCGCTCCCCTTGGA-3' and 5'-GCATCTTCAT- 
TAATTATTCA-3' and yielding a 309 bp product) was used to screen 
a collection of YAC clones highly enriched for human chromosome 7 
(Green et al., 1995). Two positive YAC clones were identified 
(yWSS2193 and yWSS1759), both contained within a larger contig that 
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includes YACs positive for the genetic marker D7S505 (Green et al., 
1994). 
FISH 
Metaphase chromosome spreads were prepared from normal cultured 
lymphocytes (46 X,Y) by standard procedures of colcimid arrest, hypo- 
tonic treatment, and acetic acid-methanol fixation. HERG P1 clone 
16B4 was labeled by incorporation of biotin-14-dATP (BioNick System, 
GIBCO BRL), hybridized to metaphase spreads, and detected with 
streptavidin-Cy3 according to standard methods (Lichter et al., 1988). 
A digoxigenin-labeled centromere-specific e-satellite probe (Oncor) 
was cohybridized and detected with antidigoxigenin-FITC to identify 
chromosome 7. Chromosomes were counterstained with DAPI and 
visualized directly on the photomicroscope. 
SSCP and DNA Sequence Analyses 
Genomic DNA samples were amplified by PCR and used in SSCP 
analyses as described (Orita et al., 1989; Ptacek et al., 1991). Primer 
pairs used for this study are shown in Table 2. Annealing temperature 
was 58°C for all PCRs. Reactions (10 pl) were diluted with 40 pl of 
0.1% SDS and 1 mM EDTA and with 30 I~1 of 95% formamide dye. 
Diluted products were denatured by heating at 100°C for 5 min, and 
3 p_l of each sample was electrophoresed on 7.5% nondenaturing 
polyacrylamide gels (49:1 polyacrylamide:bisacrylamide) at 4°C. Elec- 
trophoreses was carried out at 40 W for 2-5 hr. Gels were transferred 
to filter paper, dried, and exposed to X-ray film at -80°C for 12-36 hr. 
Normal and aberrant SSCP conformers were cut directly from dried 
gels and eluted in 75 pl of distilled water at 37°C for 30 min. The 
eluted DNA (10 '#1) was used as template for a second PCR using the 
original primer pair. Products were fractionated in 2% low melting 
temperature agarose gels (FMC Corporation), and bands were cloned 
directly into pBluescript II SK(+) (Stratagene) using the T vector 
method as described (Marchuk et al., 1990). Plasmid DNA samples 
were purified and sequenced as previously described (Curran et ai., 
1993b). 
Northern Blot Analysis 
A multiple tissue Northern blot containing -2  p.g/lane of poiy(A) + 
mRNA was purchased from Clontech (human MTN blot 1). A high 
specific activity (>1.5 x 109 cpm/pg DNA) and radiolabeled HERG 
cDNA fragment containing nucleotides 679-2239 of the coding se- 
quence was prepared by random hexamer priming as described 
(Feinberg and Vogelstein, 1983). Probe was added to the hybridization 
solution at a final concentration of 5 x 10 s cpm/ml. Hybridization was 
carried out at 42°C for 24 hr in 20 ml of Quickhyb solution (Stratagene). 
Final washes were carried out at 65°C for 30 rain in a solution of 0.1% 
SDS, 0.1 x SSC. 
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